Kingston Health Sciences Centre
Kingston Health Sciences Centre
Kingston, Ontario, Canada5 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass | Blood Protein Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, blood coagulation disease, hematologic disorder, hereditary antithrombin deficiency, hereditary disease, inherited blood coagulation disorder, thrombophilia | Recruiting | Phase 3 | 2026-09-28 | NCT06096116 | |
| Vaginal Estrogen for Improvement of Outcomes Following Pelvic Organ Prolapse Surgery | Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Prolapse, pelvic organ prolapse | Recruiting | Phase 3 | 2026-08-20 | NCT07030426 | |
| Clinical Surveillance Tool to Screen for Unmet Palliative Needs Among Patients in the Final Year of Life | Death, Pathologic Processes, Pathological Conditions, Signs and Symptoms | Enrolling by invitation | Not applicable | 2026-07-20 | NCT04171830 | |
| Neurologic Physiology After Removal of Therapy (NeuPaRT) | Death, Determination of Death, Pathologic Processes, Pathological Conditions, Signs and Symptoms | Recruiting | Not stated | 2026-01-30 | NCT05306327 | |
| Magnesium Prophylaxis for the Prevention of New-Onset Atrial Fibrillation in Critically Ill Patients | Critical Illness, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms | Recruiting | Phase 4 | 2025-09-22 | NCT05829317 |